Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Samhwang-Sasimtang extract promotes hair growth and has strong antioxidant properties.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Storing hair follicles in special buffers with added protective substances can increase hair growth and reduce cell death.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Cow placenta extract has strong antioxidant effects and can delay skin aging in mice.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Neurosteroids help control dopamine responses in the brain.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.